DLBCL treatment side effects: daily management and urgent symptoms

Side effects during DLBCL treatment should not all be dismissed as normal. Nausea, constipation, fatigue and neuropathy can often be planned for, while infection, tumor lysis, serious infusion reactions and immune-treatment toxicity may need urgent intervention. Before the first cycle, obtain instructions matched to the actual regimen, supportive prescriptions and daytime and overnight contacts. [S1,S8,S20]

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Fever of 38°C or above, shaking chills, major breathlessness, chest pain, confusion, persistent bleeding, seizure or inability to drink warrants prompt contact and emergency assessment when directed. After recent chemotherapy, do not wait for a same-day count to prove neutropenia. Fever-reducing medicines can obscure a useful sign. [S8]
Vincristine, anti-nausea medicines, reduced activity and other factors can contribute to constipation. Record the last bowel movement, bloating, passage of gas and remedies used. Severe pain or inability to pass gas needs assessment rather than simply more laxatives, especially with known gastrointestinal lymphoma. [S1]
Before treatment, identify who arranges blood tests, growth factors, transfusions, antimicrobials and emergency admission. Discharge does not automatically establish fitness for long-distance travel after immune therapy or severe cytopenias; monitoring and transport need assessment. [S14]

Quick answer

Full guide

Severity does not establish efficacy, and another patient's experience cannot predict every reaction. Record onset, relation to treatment and effects on daily function. That information helps the team decide about tests, supportive medicines or dose changes. Neither self-directed stopping nor enduring every problem without reporting it is a reliable strategy.

Recognize symptoms that need immediate help

Fever of 38°C or above, shaking chills, major breathlessness, chest pain, confusion, persistent bleeding, seizure or inability to drink warrants prompt contact and emergency assessment when directed. After recent chemotherapy, do not wait for a same-day count to prove neutropenia. Fever-reducing medicines can obscure a useful sign. [S8]

Carry the last chemotherapy, bispecific or CAR T date, regimen, allergies and center contact. The emergency team needs the treatment context to consider infection, immune reactions and other causes. A patient in a hotel abroad should not only message a distant hospital and wait; local assessment and contact with the original team can proceed together.

Distinguish the consequences of low blood counts

Low neutrophils increase infection risk, anemia can cause fatigue or breathlessness, and low platelets can increase bleeding. They are different problems requiring different assessments. Monitoring, growth factors or transfusion decisions depend on the cycle, symptoms and health history, not the total white count alone. [S20]

Keep the absolute neutrophil count, hemoglobin, platelets and sampling date. Report ongoing nose or mouth bleeding, black stool, blood in urine or a new severe headache. Avoid independently choosing painkillers that may worsen bleeding. Transfusion thresholds are individualized; another patient's number is not an instruction for your care.

Use infection prevention that fits the treatment

Hand hygiene, line care, food safety and avoiding clearly infectious contacts are practical measures. Antiviral, antibacterial or other prevention and growth-factor support depend on risk. Hepatitis B screening and the resulting plan matter even when a previous infection caused no recent symptoms. [S3,S8]

Protection should be balanced with adequate food, activity and family support rather than complete social isolation. Ask what to do when someone in the household becomes ill. Immune recovery can lag behind routine blood-count recovery, and vaccinations require advice based on the medicines and timing. [S14]

Follow tumor-lysis prevention and laboratory monitoring

Rapid destruction of a large lymphoma burden can disturb uric acid, electrolytes and kidney function. High burden, rapid proliferation or poor renal function can justify close observation at treatment initiation. The team may prescribe hydration, uric-acid management and repeated tests, sometimes in hospital. [S3]

Do not independently force fluids or add medication, especially with heart or kidney disease. Reduced urine, persistent vomiting, cramps, palpitations or altered thinking needs assessment, though these symptoms have other possible causes. Scheduled laboratory monitoring can detect abnormalities before symptoms become obvious; feeling well is not a reason to cancel it.

Separate infusion reactions from later immune toxicity

During rituximab or another infusion, immediately report rash, chills, chest discomfort or breathing changes. Staff may pause treatment, alter the rate or give medication. Record the dose and stage at which the reaction occurred and how it was managed for future administration planning. [S3]

CAR T cells and bispecific antibodies can cause cytokine release syndrome and neurological toxicity, involving fever, blood pressure, breathing, language or thinking. [S6,S7,S11] Infection may resemble or coexist with these problems. Caregivers should report sudden writing, speech, alertness or behavior changes according to the center's instructions rather than assuming fatigue is the cause.

Address nausea and mouth problems before intake collapses

Preventive anti-nausea schedules may differ from rescue treatment, so clarify both. Repeated vomiting, inability to drink, dizziness or reduced urine can require fluids and testing. Mouth pain, swallowing difficulty or white patches may represent mucosal injury or infection and deserve assessment. [S20,S21]

Adapt food texture, temperature and portion size to the symptom while maintaining nutrition. There is no need to force a particular anticancer food or remove many ordinary foods until energy intake becomes inadequate. Request dietitian support for substantial weight loss or prolonged poor intake. Offering small choices can be more useful than turning every meal into a confrontation.

Describe constipation, diarrhea and abdominal pain separately

Vincristine, anti-nausea medicines, reduced activity and other factors can contribute to constipation. Record the last bowel movement, bloating, passage of gas and remedies used. Severe pain or inability to pass gas needs assessment rather than simply more laxatives, especially with known gastrointestinal lymphoma. [S1]

For diarrhea, record frequency, blood, fever and drinking ability. Infection, drugs and radiation effects can require different treatment. Avoid repeatedly alternating strong antidiarrheal and laxative medicines without advice. Black or markedly bloody stool, rigidity or faintness should prompt urgent local care rather than waiting for the next cycle.

Report nerve effects through their impact on function

Vincristine, polatuzumab and some other treatments may cause or worsen neuropathy. Mention even early tingling before each dose, particularly with diabetes or pre-existing nerve disease. Difficulty fastening buttons, dropping objects, walking instability, pain or progressive symptoms gives the doctor useful information. [S4,S20]

A medicine or dose change may prevent further injury; do not wait until walking becomes impossible before discussing it. Protect against falls, burns and unnoticed foot injuries, with rehabilitation tailored to function. Supplements advertised for nerve repair cannot guarantee recovery and should be checked for interactions.

Bring heart, kidney and steroid problems to attention

Doxorubicin treatment requires baseline and clinically appropriate later cardiac assessment. New chest pain, breathlessness when lying down, substantial swelling or persistent palpitations should not be labeled ordinary fatigue without review. Kidney changes affect medicines, fluid plans and testing, making current results and urine history important. [S3]

Steroids can disturb sleep, mood and glucose. People with diabetes need a coordinated plan, and severe thirst, vomiting or altered thinking requires advice. Do not omit prescribed steroid doses to improve sleep or add sedating medicines independently. Review long-term medicines and supplements together to reduce conflicting prescriptions.

Match radiation advice to the actual field

Neck, chest, abdominal and bone radiation produce different concerns. Swallowing, skin, bowel and fatigue symptoms depend on the exposure; recent chemotherapy can simultaneously contribute infection risk or low counts. A generic whole-body care list cannot replace the radiation team's instructions. [S15]

Describe pre-existing symptoms and medicines so new problems are not automatically attributed to radiation. If interruption is necessary, obtain a rescheduling plan. Keep the total dose and field at completion for later evaluation of possible thyroid, cardiac, lung or other late effects.

Ask directly about fertility and sexual health

Chemotherapy and selected radiation fields can affect reproductive function. Preservation should be discussed before treatment when possible. Pregnancy timing afterward requires advice based on the medicines, age and recovery; return of periods is not a complete assessment of ovarian reserve. Do not independently reduce anticancer treatment to protect fertility. [S9]

Fatigue, body-image changes, dryness or altered desire can affect relationships and can be discussed with the team. Contraception and sexual-health advice should fit the current counts and treatment phase. A person who did not preserve fertility before treatment can still seek specialist assessment without assuming that raising the subject is too late or inappropriate.

Investigate persistent fatigue and emotional distress

Anemia, sleep, nutrition, pain and medicines can contribute to fatigue. Persistent severe fatigue deserves assessment. Activity can be rebuilt gradually according to cardiac, blood-count and neurological status. Caregivers can redistribute tasks rather than expecting the patient to maintain their previous workload immediately. [S12]

Scan anxiety, fear of relapse and a prolonged stay away from home can also affect function. Seek psychological or social support when sleep, sadness or fear substantially disrupts life. Describing the activities that are possible today is more informative than judging personal strength. Emotional distress is a legitimate treatment burden.

Include support and complication care in China planning

Before treatment, identify who arranges blood tests, growth factors, transfusions, antimicrobials and emergency admission. Discharge does not automatically establish fitness for long-distance travel after immune therapy or severe cytopenias; monitoring and transport need assessment. [S14]

A Chinese-yuan budget should include supportive drugs, repeat tests, nutrition or rehabilitation, possible readmission and caregiver housing. This article has no verified individualized complication costs and cannot promise a total covering every event. [S10] Before returning home, transfer the toxicities already experienced, their management, unresolved problems and the next review date so the receiving doctor can avoid preventable recurrence.

With glofitamab, severe inflammation may also reflect HLH. The manufacturer's January 2026 letter includes fatal reports and distinguishes its treatment from CRS management. Persistent or delayed deterioration requires urgent hospital evaluation; patients should not attempt to diagnose the distinction themselves. [S33]